A carregar...
Galunisertib enhances chimeric antigen receptor-modified T cell function
Chimeric antigen receptor (CAR) T cell therapy still faces the challenge of immunosuppression when treating solid tumors. TGF-β is one of the critical factors in the tumor microenvironment to help tumors escape surveillance by the immune system. Here we tried using the combination of a small molecul...
Na minha lista:
| Publicado no: | Eur J Histochem |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
PAGEPress Publications, Pavia, Italy
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7388644/ https://ncbi.nlm.nih.gov/pubmed/32705856 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4081/ejh.2020.3122 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|